These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27025327)

  • 1. Global platform to inform investments for health R&D.
    Kieny MP; Viergever RF; Adam T; Boerma T; Røttingen JA
    Lancet; 2016 Mar; 387(10024):1157. PubMed ID: 27025327
    [No Abstract]   [Full Text] [Related]  

  • 2. Global public and philanthropic investment in childhood cancer research: systematic analysis of research funding, 2008-16.
    Loucaides EM; Fitchett EJA; Sullivan R; Atun R
    Lancet Oncol; 2019 Dec; 20(12):e672-e684. PubMed ID: 31797794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Funding: Donor drugs.
    Willyard C
    Nature; 2016 May; 533(7601):S43-5. PubMed ID: 27144609
    [No Abstract]   [Full Text] [Related]  

  • 4. Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?
    Røttingen JA; Regmi S; Eide M; Young AJ; Viergever RF; Ardal C; Guzman J; Edwards D; Matlin SA; Terry RF
    Lancet; 2013 Oct; 382(9900):1286-307. PubMed ID: 23697824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The allocation of USdollar;105 billion in global funding from G20 countries for infectious disease research between 2000 and 2017: a content analysis of investments.
    Head MG; Brown RJ; Newell ML; Scott JAG; Batchelor J; Atun R
    Lancet Glob Health; 2020 Oct; 8(10):e1295-e1304. PubMed ID: 32971052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fund global health: Save lives and money.
    Galvani AP; Fitzpatrick MC; Vermund SH; Singer BH
    Science; 2017 Jun; 356(6342):1018-1019. PubMed ID: 28596330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping global health research investments, time for new thinking--a Babel Fish for research data.
    Terry RF; Allen L; Gardner CA; Guzman J; Moran M; Viergever RF
    Health Res Policy Syst; 2012 Sep; 10():28. PubMed ID: 22938160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A global biomedical R&D fund and mechanism for innovations of public health importance.
    Balasegaram M; Bréchot C; Farrar J; Heymann D; Ganguly N; Khor M; Lévy Y; Matsoso P; Minghui R; Pécoul B; Peilong L; Tanner M; Røttingen JA
    PLoS Med; 2015 May; 12(5):e1001831. PubMed ID: 25962119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creating a global observatory for health R&D.
    Terry RF; Salm JF; Nannei C; Dye C
    Science; 2014 Sep; 345(6202):1302-4. PubMed ID: 25214621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Funding: Global Alliance for Chronic Diseases tackles diabetes.
    Frood A
    Lancet; 2013 Sep; 382(9897):1014. PubMed ID: 24063028
    [No Abstract]   [Full Text] [Related]  

  • 11. What research is needed to stop TB? Introducing the TB Research Movement.
    Lienhardt C; Espinal M; Pai M; Maher D; Raviglione MC
    PLoS Med; 2011 Nov; 8(11):e1001135. PubMed ID: 22140369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resource allocation for biomedical research: analysis of investments by major funders.
    Ralaidovy AH; Adam T; Boucher P
    Health Res Policy Syst; 2020 Feb; 18(1):20. PubMed ID: 32066463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new deal for global health R&D? The recommendations of the Consultative Expert Working Group on Research and Development (CEWG).
    Røttingen JA; Chamas C
    PLoS Med; 2012; 9(5):e1001219. PubMed ID: 22615545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood tuberculosis: a unified response to a global problem.
    Bassyouni H; Breugelmans JG; Surette M; Olesen O
    Int J Tuberc Lung Dis; 2015 Dec; 19 Suppl 1():54. PubMed ID: 26564543
    [No Abstract]   [Full Text] [Related]  

  • 15. The cancer megafund: determinants of success.
    Marko NF
    Nat Biotechnol; 2013 Jun; 31(6):492-4. PubMed ID: 23752428
    [No Abstract]   [Full Text] [Related]  

  • 16. The cancer megafund: a catalyst for disruptive innovation.
    Tenenbaum JM
    Nat Biotechnol; 2013 Jun; 31(6):491-2. PubMed ID: 23752427
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing the value of America's investment in medical research.
    Hunt N
    MedGenMed; 2003 Jan; 5(1):34. PubMed ID: 12827095
    [No Abstract]   [Full Text] [Related]  

  • 18. The cancer megafund: mathematical modeling needed to gauge risk.
    Boissel FH
    Nat Biotechnol; 2013 Jun; 31(6):494. PubMed ID: 23752429
    [No Abstract]   [Full Text] [Related]  

  • 19. Charity begins at home in global health research funding.
    Abimbola S; Negin J; Martiniuk A
    Lancet Glob Health; 2017 Jan; 5(1):e25-e27. PubMed ID: 27955774
    [No Abstract]   [Full Text] [Related]  

  • 20. Market watch: Evolution of Chinese bioclusters as a framework for investment policies in emerging markets.
    Gautam A
    Nat Rev Drug Discov; 2015 Jan; 14(1):8. PubMed ID: 25503337
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.